Question 1

What is Revance Therapeutics, Inc. (RVNC) stock price today?

Accepted Answer

Revance Therapeutics, Inc. (RVNC) currently trades at $3.65 per share. The stock has a market capitalization of $381.02M and a P/E ratio of —x.

Question 2

Is RVNC stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Revance Therapeutics, Inc. has a Smart Value Score of 32/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Revance Therapeutics, Inc.'s revenue and earnings?

Accepted Answer

Revance Therapeutics, Inc. has trailing twelve-month (TTM) revenue of $256.94M with profit margins of -71.80%. Earnings per share (EPS) is $-3.34.

Question 4

Is RVNC stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Revance Therapeutics, Inc.'s intrinsic value is $10.56, representing a margin of safety of 65.44%. The stock currently trades at a P/E of —x.

Metric	2020	2021	2022	2023	TTM
Revenue	$15.32M	$77.80M	$132.56M	$234.04M	$256.94M
Net income	$-282.09M	$-286.82M	$-356.42M	$-323.99M	$-35.12M
EPS	—	—	—	—	$-3.34
Free cash flow	$-182.72M	$-239.61M	$-216.56M	$-223.46M	$-41.15M
Profit margin	-1,840.71%	-368.68%	-268.87%	-138.43%	-71.80%

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RVNC	$381.02M	32	6.7	2.0	6.7	5.0	+65.44%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Revance Therapeutics, Inc.

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare